Salem Investment Counselors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.52K | Hold |
55
| – | – | ﹤0.01% | 1062 |
|
|
2025
Q1 | $1.56K | Hold |
55
| – | – | ﹤0.01% | 1068 |
|
|
2024
Q4 | $2.29K | Sell |
55
-154
| -74% | -$6.4K | ﹤0.01% | 1007 |
|
|
2024
Q3 | $14K | Buy |
209
+4
| +2% | +$267 | ﹤0.01% | 797 |
|
|
2024
Q2 | $24.3K | Sell |
205
-10
| -5% | -$1.19K | ﹤0.01% | 696 |
|
|
2024
Q1 | $22.9K | Buy |
215
+150
| +231% | +$16K | ﹤0.01% | 692 |
|
|
2023
Q4 | $6.47K | Sell |
65
-819
| -93% | -$81.5K | ﹤0.01% | 872 |
|
|
2023
Q3 | $91.3K | Sell |
884
-108
| -11% | -$11.2K | ﹤0.01% | 429 |
|
|
2023
Q2 | $121K | Sell |
992
-16
| -2% | -$1.94K | ﹤0.01% | 388 |
|
|
2023
Q1 | $155K | Hold |
1,008
| – | – | 0.01% | 368 |
|
|
2022
Q4 | $181K | Buy |
1,008
+24
| +2% | +$4.31K | 0.01% | 345 |
|
|
2022
Q3 | $116K | Buy |
984
+100
| +11% | +$11.8K | 0.01% | 375 |
|
|
2022
Q2 | $126K | Hold |
884
| – | – | 0.01% | 384 |
|
|
2022
Q1 | $152K | Buy |
884
+28
| +3% | +$4.81K | 0.01% | 373 |
|
|
2021
Q4 | $217K | Buy |
856
+12
| +1% | +$3.04K | 0.01% | 362 |
|
|
2021
Q3 | $325K | Buy |
844
+4
| +0.5% | +$1.54K | 0.02% | 286 |
|
|
2021
Q2 | $197K | Buy |
840
+250
| +42% | +$58.6K | 0.01% | 329 |
|
|
2021
Q1 | $77K | Hold |
590
| – | – | ﹤0.01% | 394 |
|
|
2020
Q4 | $62K | Buy |
+590
| New | +$62K | ﹤0.01% | 394 |
|